Cargando…

Decipher the Immunopathological Mechanisms and Set Up Potential Therapeutic Strategies for Patients with Lupus Nephritis

Lupus nephritis (LN) is one of the most severe complications in patients with systemic lupus erythematosus (SLE). Traditionally, LN is regarded as an immune complex (IC) deposition disease led by dsDNA–anti-dsDNA-complement interactions in the subendothelial and/or subepithelial basement membrane of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tsai, Chang-Youh, Li, Ko-Jen, Shen, Chieh-Yu, Lu, Cheng-Hsun, Lee, Hui-Ting, Wu, Tsai-Hung, Ng, Yee-Yung, Tsao, Yen-Po, Hsieh, Song-Chou, Yu, Chia-Li
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10298725/ https://www.ncbi.nlm.nih.gov/pubmed/37373215 http://dx.doi.org/10.3390/ijms241210066

Ejemplares similares

Potential serum and urine biomarkers in patients with lupus nephritis and the unsolved problems
por: Hsieh, Song-Chou, et al.
Publicado: (2016)

Deranged Bioenergetics and Defective Redox Capacity in T Lymphocytes and Neutrophils Are Related to Cellular Dysfunction and Increased Oxidative Stress in Patients with Active Systemic Lupus Erythematosus
por: Li, Ko-Jen, et al.
Publicado: (2012)

Urinary Neutrophil Gelatinase-Associated Lipocalin Is a Potential Biomarker for Renal Damage in Patients with Systemic Lupus Erythematosus
por: Yang, Chun-Chen, et al.
Publicado: (2012)

Molecular and Cellular Bases of Immunosenescence, Inflammation, and Cardiovascular Complications Mimicking “Inflammaging” in Patients with Systemic Lupus Erythematosus
por: Tsai, Chang-Youh, et al.
Publicado: (2019)

Trogocytosis between Non-Immune Cells for Cell Clearance, and among Immune-Related Cells for Modulating Immune Responses and Autoimmunity
por: Li, Ko-Jen, et al.
Publicado: (2021)

Leukocyte Mitochondrial DNA Alteration in Systemic Lupus Erythematosus and Its Relevance to the Susceptibility to Lupus Nephritis
por: Lee, Hui-Ting, et al.
Publicado: (2012)

NLRP12 is an innate immune checkpoint for repressing IFN signatures and attenuating lupus nephritis progression
por: Tsao, Yen-Po, et al.
Publicado: (2023)

NLRP12 is an innate immune checkpoint for repressing IFN signatures and attenuating lupus nephritis progression
por: Tsao, Yen-Po, et al.
Publicado: (2023)

Sjögren’s Syndrome Antigen B Acts as an Endogenous Danger Molecule to Induce Interleukin-8 Gene Expression in Polymorphonuclear Neutrophils
por: Wu, Cheng-Han, et al.
Publicado: (2015)

EGF Receptor-Dependent Mechanism May be Involved in the Tamm–Horsfall Glycoprotein-Enhanced PMN Phagocytosis via Activating Rho Family and MAPK Signaling Pathway
por: Li, Ko-Jen, et al.
Publicado: (2014)

Aberrant Non-Coding RNA Expression in Patients with Systemic Lupus Erythematosus: Consequences for Immune Dysfunctions and Tissue Damage
por: Tsai, Chang-Youh, et al.
Publicado: (2020)

Molecular Basis for Paradoxical Activities of Polymorphonuclear Neutrophils in Inflammation/Anti-Inflammation, Bactericide/Autoimmunity, Pro-Cancer/Anticancer, and Antiviral Infection/SARS-CoV-II-Induced Immunothrombotic Dysregulation
por: Wu, Tsai-Hung, et al.
Publicado: (2022)

The Role of hOGG1 C1245G Polymorphism in the Susceptibility to Lupus Nephritis and Modulation of the Plasma 8-OHdG in Patients with Systemic Lupus Erythematosus †
por: Lee, Hui-Ting, et al.
Publicado: (2015)

Tamm–Horsfall Protein is a Potent Immunomodulatory Molecule and a Disease Biomarker in the Urinary System
por: Wu, Tsai-Hung, et al.
Publicado: (2018)

Pathogenic Roles of Autoantibodies and Aberrant Epigenetic Regulation of Immune and Connective Tissue Cells in the Tissue Fibrosis of Patients with Systemic Sclerosis
por: Tsai, Chang-Youh, et al.
Publicado: (2020)

Tamm-Horsfall Glycoprotein Enhances PMN Phagocytosis by Binding to Cell Surface-Expressed Lactoferrin and Cathepsin G That Activates MAP Kinase Pathway
por: Siao, Syue-Cian, et al.
Publicado: (2011)

Epidemiology and risk of invasive fungal infections in systemic lupus erythematosus: a nationwide population-based cohort study
por: Su, Chin-Fang, et al.
Publicado: (2021)

The Cellular and Molecular Bases of Allergy, Inflammation and Tissue Fibrosis in Patients with IgG4-related Disease
por: Hsieh, Song-Chou, et al.
Publicado: (2020)

Cross-Talk between Mitochondrial Dysfunction-Provoked Oxidative Stress and Aberrant Noncoding RNA Expression in the Pathogenesis and Pathophysiology of SLE
por: Tsai, Chang-Youh, et al.
Publicado: (2019)

The Potential Role of Genetics, Environmental Factors, and Gut Dysbiosis in the Aberrant Non-Coding RNA Expression to Mediate Inflammation and Osteoclastogenic/Osteogenic Differentiation in Ankylosing Spondylitis
por: Liao, Hsien-Tzung, et al.
Publicado: (2022)

The Association between Autoantibodies and Peripheral Neuropathy in Lupus Nephritis
por: Su, Yu-Jih, et al.
Publicado: (2014)

The Expression of Non-Coding RNAs and Their Target Molecules in Rheumatoid Arthritis: A Molecular Basis for Rheumatoid Pathogenesis and Its Potential Clinical Applications
por: Tsai, Chang-Youh, et al.
Publicado: (2021)

Characteristics of comorbidities and costs among patients who died from systemic lupus erythematosus in Taiwan
por: Kang, Shih-Chao, et al.
Publicado: (2012)

Change of Renal Gallium Uptake Correlated with Change of Inflammation Activity in Renal Pathology in Lupus Nephritis Patients
por: Hsieh, Tsu-Yi, et al.
Publicado: (2021)

Individualizing Therapy in Lupus Nephritis
por: An, Yu, et al.
Publicado: (2019)

Cross-Talk among Polymorphonuclear Neutrophils, Immune, and Non-Immune Cells via Released Cytokines, Granule Proteins, Microvesicles, and Neutrophil Extracellular Trap Formation: A Novel Concept of Biology and Pathobiology for Neutrophils
por: Tsai, Chang-Youh, et al.
Publicado: (2021)

The Binding Affinity and Molecular Basis of the Structure-Binding Relationship between Urinary Tamm-Horsfall Glycoprotein and Tumor Necrosis Factor-α
por: Wu, Cheng-Han, et al.
Publicado: (2012)

Biomarker Profiling for Lupus Nephritis
por: Li, Yajuan, et al.
Publicado: (2013)

The Pathogenesis of Lupus Nephritis
por: Sterner, Rosalie M., et al.
Publicado: (2014)

Pediatric lupus nephritis
por: Pinheiro, Sergio Veloso Brant, et al.
Publicado: (2018)

Hyperhomocysteinemia and Lupus Nephritis
por: Timlin, Homa, et al.
Publicado: (2019)

Management of Lupus Nephritis
por: Tamirou, Farah, et al.
Publicado: (2021)

Lupus Nephritis and Dysbiosis
por: Monticolo, Marta, et al.
Publicado: (2023)

The Role of Hyaluronan and CD44 in the Pathogenesis of Lupus Nephritis
por: Yung, Susan, et al.
Publicado: (2012)

Renal microvascular lesions in lupus nephritis
por: Ding, Ying, et al.
Publicado: (2019)

Accelerated and Severe Lupus Nephritis Benefits From M1, an Active Metabolite of Ginsenoside, by Regulating NLRP3 Inflammasome and T Cell Functions in Mice
por: Lin, Tsai-Jung, et al.
Publicado: (2019)

Fetal and maternal outcome in patients with active lupus nephritis: comparison between new-onset and pre-existing lupus nephritis
por: Lian, Xing-Ji, et al.
Publicado: (2021)

Molecular characterization of proliferative lupus nephritis
por: Parikh, Samir V, et al.
Publicado: (2014)

Cytotoxic T lymphocyte-associated antigen-4-Ig (CTLA-4-Ig) suppresses Staphylococcus aureus-induced CD80, CD86, and pro-inflammatory cytokine expression in human B cells
por: Liu, Po-Chun, et al.
Publicado: (2020)

Tubulointerstitial lesions converted into lupus nephritis
por: Yang, Ning, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_cl2okovncctlvplf1g22j75jo9